About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Samsung Bioepis Releases 2023 Sustainability Report

By: via GlobeNewswire
  • Highlights key initiatives that will drive the company’s transition towards a more sustainable business
  • Reaffirms commitment to environmentally and socially responsible practices in R&D, clinical trials, manufacturing, and supply chain management to enable access to high-quality biological medicines for patients in need

INCHEON, Korea, June 30, 2023 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today released its 2023 sustainability report, highlighting its progress toward building more sustainable and socially responsible practices in research and development (R&D), clinical trials, manufacturing, and supply chain management.

“The consequences of the COVID-19 pandemic such as global supply chain disruptions, as well as the growing challenges of climate change have highlighted the importance of sustainable business, and this report embodies our commitment to reinforcing our environment, social, governance values and initiatives,” said Christopher Hansung Ko, President and Chief Executive Officer at Samsung Bioepis. “We will provide patients with wide-ranging portfolio of biologics products at affordable prices and promote win-win partnerships across the bio industry ecosystem.”

Together with Samsung Biologics, Samsung Bioepis is committed to joining the RE100 initiative, a group of global corporations pledging to shift to 100% renewable energy by 2050, and the company also targets to reach net-zero emissions by 2050.

The annual report provides a comprehensive overview of Samsung Bioepis’ performance and management of the company’s commitment to sustainability, and key highlights of the report are as follows:

Driving R&D Innovation
Samsung Bioepis pursues transformation and innovation throughout its business activities to drive its sustainable growth and to help address important issues that matter to our business, our stakeholders and society.
The company’s innovative research and development is the key to increase access to scientifically-proven medicines for patients around the world and unlock the potential of biosimilars.

Ensuring Product Quality and Patient Safety
Ensuring product quality and patient safety are at the center of Samsung Bioepis’ vision and priorities. Samsung Bioepis has rigorous quality management system in compliance with global standards to prevent quality risks.
Clinical trials are a critical part of patient safety, and Samsung Bioepis strives to adhere to strict global standards when it comes to pre-clinical and clinical trials.

Enhancing Access to Medicines
Samsung Bioepis holds on the mission of innovating access to medicines for patients worldwide. At the core of our business and vision are the patients around the world without viable treatment options, and the company is further committed to fulfilling its social responsibility and becoming a sustainable company.

Building Sustainable Supply Chain Management
Samsung Bioepis emphasizes the importance of ensuring that its products are delivered on time, so that patients can receive treatments at the right time. Sustainable supply chain management and supply continuity are the most important aspects of the company’s mission and promise to patients that we will deliver the high-quality medicines they need.
The company also takes the impact of our activities seriously throughout the entire supply chain by conducting ESG assessments of its existing supply chains on a regular basis and reviewing its suppliers’ human rights, code of ethics and environmental performance.

The company’s report is formulated in the Core Options of the Global Reporting Initiative (GRI) Standards and details activities and achievements that are aligned with the Sustainability Accounting Standards Board (SASB). Samsung Bioepis’ detailed ESG performance can be found in the full report: https://bit.ly/3NR2obo

About Samsung Bioepis Co., Ltd.
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology and endocrinology. For more information, please visit: www.samsungbioepis.com and follow us on social media – Twitter, LinkedIn.


MEDIA CONTACT
Jane Chung, ejane.chung@samsung.com
Anna Nayun Kim, nayun86.kim@samsung.com

Primary Logo

More News

View More
Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
Via MarketBeat
Tickers BSET ETD HVT
AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon
Via MarketBeat
Tickers ASTS JOBY RGTI T VOD VZ
Catch the Next Bitcoin Rally With These 3 ETFs
Via MarketBeat
Topics ETFs
Tickers BITQ FBTC IBIT
MarketBeat Week in Review – 10/06 - 10/10
Via MarketBeat
Topics Economy
Tickers ACHR AMD AMZN AVGO CELH CRWV
3 Heavily Shorted Stocks That Could Pop on Rate Cuts
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers ETSY SMR SOUN
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.